U-NEURON Launches Exosome R&D Pilot Manufacturing Center, Targeting Healthcare and Wellness Markets
Byline / Photo Credit: Reporter Hsin-Lu Yeh, Photo Center / Hsinchu News Desk
https://video.udn.com/embed/news/1310699
U-NEURON Biomedical Co., Ltd. officially inaugurated Taiwan’s first “Exosome R&D Pilot Manufacturing Center” at the Hsinchu Biomedical Science Park. The facility integrates exosome research and development, manufacturing, efficacy validation, and translational applications, targeting the regenerative aesthetics, skincare, and healthcare industries.
U-NEURON Chairman Dr. Frank Chien stated that the company’s core operations focus on two main directions: novel drug development, and skincare and healthcare products. Using fetal stem cells derived from amniotic fluid as its core platform, U-NEURON is advancing stem cell and exosome drug development for erectile dysfunction and dry eye syndrome.
U-NEURON Biomedical Co., Ltd. officially inaugurated Taiwan’s first “Exosome R&D Pilot Manufacturing Center” at the Hsinchu Biomedical Science Park this morning, integrating exosome R&D, manufacturing, efficacy validation, and translational applications to address the regenerative aesthetics, skincare, and healthcare markets. Photo / Hsin-Lu Yeh